Hoffmann A, Kappenberger L, Jost M, Burckhardt D
Clin Cardiol. 1987 Aug;10(8):451-2. doi: 10.1002/clc.4960100808.
The effect of amiodarone on sinus node function has been studied in 9 patients with symptomatic sick sinus node as documented by Holter-ECG. All patients had programmable dual-chamber pacemakers. Sinus node activity was assessed by intermittently inhibiting the pacemakers before and after four weeks of oral amiodarone treatment. Sinus node function was not altered by amiodarone in 5 patients but was severely depressed in 4 patients. Thus, it is concluded that amiodarone cannot be used safely in all patients with the tachybrady syndrome for the treatment of symptomatic tachyarrhythmias without concomitant pacing.
通过动态心电图记录,对9例有症状的病态窦房结患者研究了胺碘酮对窦房结功能的影响。所有患者均有可编程双腔起搏器。在口服胺碘酮治疗4周前后,通过间歇性抑制起搏器来评估窦房结活动。5例患者的窦房结功能未因胺碘酮而改变,但4例患者的窦房结功能严重受抑制。因此得出结论,对于所有心动过缓-心动过速综合征患者,在无伴随起搏的情况下,不能安全地使用胺碘酮来治疗有症状的快速性心律失常。